esuberaprost   

GtoPdb Ligand ID: 8314

Synonyms: APS-314D free acid | BPS-314d
Compound class: Synthetic organic
Comment: Esuberaprost is a defined enantiomer of the racemate beraprost and represents the active enantiomer [1]. Like beraprost, the compound is a prostacyclin IP1 receptor agonist.
2D Structure
Click here for structure editor
Physico-chemical Properties
Hydrogen bond acceptors 4
Hydrogen bond donors 3
Rotatable bonds 8
Topological polar surface area 86.99
Molecular weight 398.21
XLogP 2.82
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Canonical SMILES CC#CCC(C(C=CC1C(O)CC2C1c1cccc(c1O2)CCCC(=O)O)O)C
Isomeric SMILES CC#CC[C@@H]([C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1c1cccc(c1O2)CCCC(=O)O)O)C
InChI InChI=1S/C24H30O5/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28)/b13-12+/t15-,17-,19+,20+,21-,23-/m0/s1
InChI Key CTPOHARTNNSRSR-NOQAJONNSA-N
No information available.
Summary of Clinical Use
Esuberaprost is being assessed in Phase III clinical trial as a potential treatment for pulmonary arterial hypertension (in combination with treprostinil).
Mechanism Of Action and Pharmacodynamic Effects
Like the endogenous ligand prostacyclin, esuberaprost elicits potent vasodilation and inhibition of platelet aggregation through binding to the IP1 receptor.